The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Post-transplant cyclophosphamide (PT-Cy) based haploidentical transplantation (haploHCT) versus matched sibling (MSD) or matched unrelated donor (MUD) reduced intensity conditioning (RIC) HCT for diffuse large b-cell lymphoma (DLBCL): A CIBMTR and EBMT analysis.
 
Mehdi Hamadani
Honoraria - Celgene
Consulting or Advisory Role - Celerant; Janssen Oncology; MedImmune
Speakers' Bureau - Sanofi
Research Funding - Spectrum Pharmaceuticals; Takeda
 
Kwang Woo Ahn
No Relationships to Disclose
 
Carlos Litovich
No Relationships to Disclose
 
Finel Herve
No Relationships to Disclose
 
Sonali M. Smith
Consulting or Advisory Role - Abbvie/Genentech; Amgen; AstraZeneca; Celgene; Forty Seven; Genmab; Gilead Sciences; Juno Therapeutics; Kite, a Gilead company; NanoString Technologies; Pharmacyclics; Portola Pharmaceuticals; Roche; TG Therapeutics
 
Timothy S Fenske
No Relationships to Disclose
 
Ariane Boumendil
No Relationships to Disclose
 
Sascha Dietrich
No Relationships to Disclose
 
Stephen Robinson
No Relationships to Disclose
 
Silvia Montoto
No Relationships to Disclose
 
Peter Dreger
Honoraria - Gilead Sciences; Novartis
Consulting or Advisory Role - Gilead Sciences; Janssen Oncology; Novartis (Inst); Roche (Inst)
Research Funding - Neovii (Inst); RIEMSER (Inst)
Travel, Accommodations, Expenses - Medac
 
Anna M. Sureda
No Relationships to Disclose